Capital Research Global Investors
BSX icon

Capital Research Global Investors’s Boston Scientific BSX Stock Holding History

Capital Research Global Investors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$444M Sell
7,080,887
-3,168
-0% -$253K 0.07% 179
2025
Q4 		$675M Buy
7,084,055
+450,322
+7% +$44.1M 0.12% 123
2025
Q3 		$648M Buy
6,633,733
+23,940
+0.4% +$2.48M 0.12% 129
2025
Q2 		$710M Buy
6,609,793
+665,827
+11% +$67.4M 0.14% 122
2025
Q1 		$600M Buy
5,943,966
+1,648,607
+38% +$166M 0.13% 132
2024
Q4 		$384M Buy
4,295,359
+1,790
+0% +$158K 0.08% 159
2024
Q3 		$360M Buy
4,293,569
+1,002,369
+30% +$79M 0.07% 155
2024
Q2 		$253M Buy
3,291,200
+620,774
+23% +$45.4M 0.06% 196
2024
Q1 		$183M Buy
+2,670,426
New +$172M 0.04% 234
2022
Q3 		– Sell
-1,157,193
Closed -$43.1M – 432
2022
Q2 		$43.1M Buy
+1,157,193
New +$47.1M 0.01% 341
2020
Q4 		– Sell
-1,511,525
Closed -$57.8M – 410
2020
Q3 		$57.8M Sell
1,511,525
-1,155,238
-43% -$44.5M 0.02% 315
2020
Q2 		$93.6M Buy
2,666,763
+5,496
+0.2% +$198K 0.03% 269
2020
Q1 		$86.8M Sell
2,661,267
-1,804,670
-40% -$70.5M 0.03% 247
2019
Q4 		$202M Buy
4,465,937
+7,170
+0.2% +$300K 0.06% 211
2019
Q3 		$181M Sell
4,458,767
-194
-0% -$8.22K 0.06% 215
2019
Q2 		$192M Sell
4,458,961
-1,917,874
-30% -$73.8M 0.06% 209
2019
Q1 		$245M Sell
6,376,835
-10,015,149
-61% -$383M 0.08% 192
2018
Q4 		$579M Sell
16,391,984
-3,002,544
-15% -$109M 0.2% 105
2018
Q3 		$747M Buy
19,394,528
+8,814,601
+83% +$308M 0.22% 99
2018
Q2 		$346M Buy
10,579,927
+851
+0% +$25.7K 0.09% 183
2018
Q1 		$289M Buy
10,579,076
+527
+0% +$14.3K 0.08% 200
2017
Q4 		$262M Buy
10,578,549
+1,139
+0% +$31.4K 0.08% 200
2017
Q3 		$309M Hold
10,577,410
– – 0.09% 176
2017
Q2 		$293M Buy
10,577,410
+7,404
+0.1% +$197K 0.09% 183
2017
Q1 		$263M Hold
10,570,006
– – 0.08% 197
2016
Q4 		$229M Buy
10,570,006
+4
+0% +$87 0.07% 218
2016
Q3 		$252M Hold
10,570,002
– – 0.08% 201
2016
Q2 		$247M Buy
10,570,002
+10
+0% +$216 0.08% 197
2016
Q1 		$199M Hold
10,569,992
– – 0.07% 223
2015
Q4 		$195M Hold
10,569,992
– – 0.07% 222
2015
Q3 		$173M Sell
10,569,992
-4,947,839
-32% -$84.6M 0.06% 238
2015
Q2 		$275M Sell
15,517,831
-3,260,961
-17% -$58.3M 0.09% 214
2015
Q1 		$333M Sell
18,778,792
-10,000,000
-35% -$158M 0.11% 188
2014
Q4 		$381M Sell
28,778,792
-19,193,694
-40% -$245M 0.13% 173
2014
Q3 		$567M Sell
47,972,486
-18,234,400
-28% -$230M 0.2% 126
2014
Q2 		$845M Sell
66,206,886
-12,947,440
-16% -$168M 0.3% 97
2014
Q1 		$1.07B Hold
79,154,326
– – 0.39% 75
2013
Q4 		$951M Hold
79,154,326
– – 0.35% 83
2013
Q3 		$929M Buy
79,154,326
+9,941,104
+14% +$108M 0.37% 78
2013
Q2 		$642M Buy
+69,213,222
New +$587M 0.27% 105

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Research Global Investors's BSX Position: Q1 2026 in Review

Capital Research Global Investors reduced its Boston Scientific (BSX) stake by 0.04% in Q1 2026, selling an estimated $253K and leaving 7,080,887 shares worth $444M. The position accounts for 0.07% of the portfolio, ranked #179.

Capital Research Global Investors first reported a position in BSX in Q2 2013 and has held it in 40 quarters since. The position peaked at $1.07B in Q1 2014. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Capital Research Global Investors held 7,080,887 shares of Boston Scientific worth $444M as of Q1 2026.
  • Capital Research Global Investors sold 3,168 Boston Scientific shares in Q1 2026, an estimated $253K.
  • Boston Scientific made up 0.07% of Capital Research Global Investors's portfolio in Q1 2026, its #179 holding.
  • Capital Research Global Investors first reported a position in Boston Scientific in Q2 2013 and has held it in 40 quarters since.
  • Capital Research Global Investors's Boston Scientific position peaked at $1.07B in Q1 2014.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.